Neurochemical changes in the pedunculopontine nucleus of hemiparkinsonian rats and effect of different treatments



Título del documento: Neurochemical changes in the pedunculopontine nucleus of hemiparkinsonian rats and effect of different treatments
Revista: Biotecnología aplicada
Base de datos: PERIÓDICA
Número de sistema: 000351070
ISSN: 0864-4551
Autores: 1
2
3
3
2
2
2
4
5
Instituciones: 1Centro Internacional de Restauración Neurológica, Departamento de Neurofisiología Experimental, La Habana. Cuba
2Centro Internacional de Restauración Neurológica, Departamento de Neuroinmunoquímica, La Habana. Cuba
3Centro Internacional de Restauración Neurológica, Departamento de Neurobiología, La Habana. Cuba
4Centro Internacional de Restauración Neurológica, Clínica de Trastornos del Movimiento, La Habana. Cuba
5Centro Internacional de Restauración Neurológica, Subdirección de Ciencia y Tecnología, La Habana. Cuba
Año:
Volumen: 27
Número: 1
Paginación: 66-68
País: Cuba
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Experimental, aplicado
Resumen en inglés The present work focuses on the physiopathology of Parkinson’s disease (PD), analyzing the alterations in neurotransmitter profile of the basal ganglia triggered by the degeneration of cells from the substantia nigra compacta (SNpc). For this purpose, the neurochemical, morphological and molecular changes of the pedunculopontine nucleus (PPN) of rats upon the induction of hemiparkinsonism were evaluated with surgical, immunochemical and molecular biology techniques together with cerebral microdialysis and behavioral tests, also examining the effect of systemic treatments with MK-801 or (-) nicotine or the results of subthalamic injury on these changes. The results evidenced an increase in the extracellular concentration (EC) of glutamate (Glu) (p < 0.001) and GABA (p < 0.001) as well as a higher density of muscarinic receptors, together with a statistically significant decrease in the density of BDZ gabaergic receptors (p < 0.001) and mu opioid receptors (p < 0.01) in the PPN of hemiparkinsonian rats. Our results also constitute the first published description of cell death in the PPN of hemiparkinsonian rats. All the treatments achieved a statistically significant decrease in the Glu (p < 0.01) and GABA (p < 0.001) EC in the PPN, with a neuroprotective effect on the dopaminergic cells of the ventral tegmental area and the SNpc itself. The administration of (-) nicotine improved the striatal expression of brain-derived neurotrophic factor (p < 0.01). We conclude that the PPN of hemiparkinsonian rats displays neurochemical changes which can be modified and/or reverted by the treatments described in this work. Our results had the added benefit of requiring the local manufacture of cerebral microdialysis cannulae, resulting in significant cost savings
Disciplinas: Medicina
Palabras clave: Medicina experimental,
Neurología,
Enfermedad de Parkinson,
Neurotransmisores,
Núcleo pedunculopontino,
Dopamina,
Nicotina
Keyword: Medicine,
Experimental medicine,
Neurology,
Parkinson disease,
Neurotransmitters,
Pedunculopontine nucleus,
Dopamine,
Nicotine
Texto completo: Texto completo (Ver PDF)